Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
2 clinical trials · Sponsor
◉ Watch Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis (NCT04231292) | Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd | 2020-03-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RD01 (Pegerythropoietin) in Healthy Chinese Volunteers (NCT03657238) | Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd | 2018-04-08 |
Track Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.